Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving angiotensin-converting enzymes (ACE) inhibitors are not eligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are receiving any other anti-cancer or investigational drug therapy are ineligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving belimumab (a monoclonal antibody for systemic lupus erythematosus) are not eligible
Patients who are currently receiving bisphosphonate derivatives are not eligible
Patients who are currently receiving another investigational drug
Investigational drugs: Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug are not eligible
Patients who are receiving any other anticancer or investigational drug therapy are not eligible
Patients who are currently receiving another investigational drug are not eligible
Not currently receiving anticoagulation therapy
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug
Patients who are currently receiving another investigational drug are not eligible
Patients who are currently receiving another investigational drug are not eligible